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Introduction
Although HAART therapy has radically changed the
prognosis of HIV infected patients, decreasing their
morbidity and mortality, the ARV medication produced
other clinical manifestations due to their toxicity. For
many years there was no data in the literature attesting
link between metabolic syndrome and renal disease
development. Recent epidemiological studies have found
that patients with metabolic syndrome have a high risk
of developing chronic kidney disease: chronic renal fail-
ure and nephrolithiasis.
Purpose of the study
Evaluation of the relationship between metabolic syn-
drome and the occurrence of nephrolithiasis in HIV
infected patients.
Methods
The study involved 112 patients with known HIV-AIDS
infection and metabolic syndrome in the evidence of the
Regional HIV Centre Constanta, Romania which were
compared with 100 matched control group. The para-
meters analyzed were: demographic characteristics,
weight, height, body mass index, blood pressure, medical
history, examination of urine, urea, creatinine, Na, K, Cl,
Mg, P, total serum calcium, glucose, serum triglycerides,
LDH cholesterol, HDL cholesterol, CD4+ lymphocytes,
HIV-RNA. Nephrolithiasis was diagnosed by ultrasound
examination. No patient had a history of treatment with
Indinavir.
Results
Of the 112 patients studied, 67 patients developed
nephrolithiasis (59.82%) in comparison with only 24% in
the control group (p < 0.01). The age of these patients
was between 20 and 67 years, with a mean age of 43.5,
sex ratio F:M = 1.09. The predominant form was bilat-
eral (69%) and asymptomatic (58%). The analysis of kid-
ney stones revealed that the major component was uric
acid (48%). Ultrasound revealed hydronephrosis in 18
patients (26.8%). Urinary tract infection was diagnosed
in 23 patients (34.3%); the most common etiology was
E. coli (39%). PCR HIV-RNA was undetectable in 90
patients (80.3%), and 46 patients had a CD4+ cell count
> 500 cells/mm
3 and only 10 patients CD4+ < 200 cells/
mm
3. The majority of patients (55.3%) received 2INRT
and PI/r as ARV treatment.
Conclusions
In HIV infected patients with metabolic syndrome under
ARV treatment, nephrolithiasis is 2.5 times more fre-
quent compared to general population. The presence of
kidney stones is a risk factor for developing hydrone-
phrosis and urinary tract infection. Because patients
with HIV infection and chronic renal failure have a
decreased survival, the screening for nephrolithiasis is
mandatory in these patients.
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